U.S. Markets closed

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.10-0.15 (-1.82%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8.25
Open8.20
Bid8.00 x 900
Ask8.98 x 2200
Day's Range8.01 - 8.20
52 Week Range3.16 - 12.71
Volume22,711
Avg. Volume35,682
Market Cap88.555M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMay 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
  • Business Wire

    LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

    ORLANDO, Fla., September 02, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright 23rd Annual Global Investment Conference.

  • Business Wire

    LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference

    ORLANDO, Fla., August 16, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021.

  • Business Wire

    LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update

    ORLANDO, Fla., August 05, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2021 and provided an update on key strategic and operational initiatives.